News

B-cell lymphoma: Cause of high-risk disease discovered

PAK1 blockade sensitizes ovarian cancer to PARP inhibitors

Mass producing engineered T cells for cancer therapy using Platinum TALEN

Vaccine against brain tumours shows promising long-term results

Do cancer screening rates differ across sexual orientation and gender identity?

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Unearthing new cancer treatments from fungi

Are lung cancer tumours hijacking the nervous system?

New targeted therapy shows promising early results in advanced pancreatic cancer

Biomarker-guided drug combinations may improve outcomes in treatment-resistant melanoma

CAR T cell therapy targets key mutation driving rare blood cancers

Study explores how “junk DNA” drives cancer